Above all, functional recovery experiments proved that silencing of LINC00152 resulted in a significant decrease in growth in ovarian cancer, and this regulation occurred via MCL‐1 and is abolished by miR‐125b inhibitors. Here, MCL1 is linked to ovarian carcinoma.